Effects of Trypanosoma cruzi infection on myocardial morphology, single cardiomyocyte contractile function and exercise tolerance in rats

International Journal of Experimental Pathology

Volumn 92, Issue 5, 2011, Pages 299-307

  Novaes, Rômulo D ^a   Penitente, Arlete R ^a   Gonçalves, Reggiani V ^a   Talvani, André ^b   Neves, Clóvis A ^a   Maldonado, Izabel R S C ^a   Natali, Antônio J ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Cellular contractility; Chagas' cardiomyopathy; Myocytes; Physical capacity

Indexed keywords

COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BIOMETRY; CELL STRUCTURE; CHAGAS DISEASE; CONTROLLED STUDY; EXERCISE TOLERANCE; FATIGUE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RIGHT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOLOGY; TREADMILL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WORKLOAD;

ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; EXERCISE TOLERANCE; HEART; HEART VENTRICLES; HYPERTROPHY; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; TRYPANOSOMA CRUZI;

EID: 80052843454     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00781.x     Document Type: Article

References (36)

1. Afanasyeva M., Georgakopoulos D., Rose N.R. (2004) Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 3, 476-486.
2. Bezerra D.G.A., Andrade L.M.L., Cruz F.O.P., Mandarim-de-lacerda C.A. (2008) Atorvastatin attenuates cardiomyocyte loss in adult rats from protein-restricted dams. J. Card. Fail. 14, 151-160.
3. Biolo A., Ribeiro A.L., Clausell N. (2010) Chagas cardiomyopathy-where do we stand after a hundred years? Prog. Cardiovasc. Dis. 52, 300-316.
4. Brener Z. (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 4, 389-396.
5. Brooks G.A., Donovan C.M., White T.P. (1984) Estimation of anaerobic energy production and efficiency in rats during exercise. J. Appl. Physiol. 56, 520-525.
6. Caldas I.S., Talvani A., Caldas S. et al. (2008) Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol. Res. 103, 413-421.
7. Chakraborti S., Chakraborti T., Shaw G. (2000) Beta-adrenergic mechanisms in cardiac diseases: a perspective. Cell. Signal. 12, 499-513.
8. Colucci W.S., Ribeiro J.P., Rocco M.B. et al. (1989) Impaired chronotropic response to exercise in patients with congestive heart failure: role of postsynaptic beta-adrenergic desensitization. Circulation 80, 314-323.
9. Gallo L. Jr, Neto J.A., Manco J.C., Rassi A., Amorim D.S. (1975) Abnormal heart rate responses during exercise in patients with Chagas' disease. Cardiology 60, 147-162.
10. Higuchi M.L., Fukasawa S., Brito T., Parzianello L.C., Bellotti G., Ramires J.A.F. (1999) Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 82, 279-285.
11. Kemi O.J. & Wisloff U. (2010) Mechanisms of exercise-induced improvements in the contractile apparatus of the mammalian myocardium. Acta Physiol. 199, 425-439.
12. Kemi O.J., Haram P.M., Wisloff U., Ellingsen O. (2004) Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 109, 2897-2904.
13. Kitzman D.W., Higginbotham M.B., Cobb F.R., Sheikh K.H., Sullivan M.J. (1991) Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J. Am. Coll. Cardiol. 17, 1065-1072.
14. Koch L.G. & Britton S.L. (2001) Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol. Genomics 5, 45-52.
15. Lacerda A.R., Marubayashi U., Balthazar C.H., Coimbra C.C. (2006) Evidence that brain nitric oxide inhibition increases metabolic cost of exercise, reducing running performance in rats. Neurosci. Lett. 393, 260-263.
16. Lima M.M.O., Pereira M.C., Rocha M.O.C., Beloti F.R., Alencar M.C.N., Ribeiro A.L.P. (2010) Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy. Echocardiography 27, 519-524.
17. López-De León A., Rojkind M. (1985) A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. Histochem. Cytochem. 33, 737-743.
18. Mady C., Ianni B.M., Arteaga E. et al. (1999) Relation between interstitial myocardial collagen and the degree of clinical impairment in Chagas' disease. Am. J. Cardiol. 84, 354-356.
19. Mady C., Ianni B.M., Arteaga E., Salemi V.M.C., Frimm C.C. (2000) Maximal functional capacity in patients with chagas' cardiomyopathy without congestive heart failure. J. Card. Fail. 3, 220-224.
20. Mandarim-de-Lacerda C.A. (2003) Stereological tools in biomedical research. An. Acad. Bras. Ciênc. 75, 469-486.
21. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simões M.V. (2007) Pathogenesis of chronic Chagas' heart disease. Circulation 115, 1109-1123.
22. Martinelli P.M., Camargos E.R.S., Azevedo A.A., Chiari E., Morel G., Machado C.R.S. (2006) Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats. Auton. Neurosci. 130, 32-40.
23. Meiler S.E.L., Ashton J.J., Moeschberger M.L., Unverferth D.V., Leier C.V. (1987) An analysis of the determinants of exercise performance in congestive heart failure. Am. Heart J. 113, 1207-1217.
24. Montes de Oca M., Torres S.H., Loyo J.G. et al. (2004) Exercise performance and skeletal muscles in patients with advanced Chagas disease. Chest 125, 1306-1314.
25. Natali A.J., Wilson L.A., Peckham M., Turner D.L., Harrison S.M., White E. (2002) Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J. Physiol. 541, 863-875.
26. Prahash A.J.C., Gupta S., Anand I.S. (2000) Myocyte response to β-adrenergic stimulation is preserved in the noninfarcted myocardium of globally dysfunctional rat hearts after myocardial infarction. Circulation 102, 1840-1846.
27. Prímola-Gomes T.N., Campos L.A., Lauton-Santos S. et al. (2009) Exercise capacity is related to calcium transients in ventricular cardiomyocytes. J. Appl. Physiol. 107, 593-598.
28. Rassi A. Jr, Rassi A., Marin-Neto J.A. (2010) Chagas disease. Lancet 375, 1388-1402.
29. Roman-Campos D., Duarte H.L.L., Sales P.A. Jr et al. (2009) Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice. Basic Res. Cardiol. 104, 238-246.
30. Scherle W. (1970) A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57-63.
31. Sousa L.A.P., Rocha M.O.C., Britto R.R., Lombardi F., Ribeiro A.L. (2009) Chagas disease alters the relationship between heart rate variability and daily physical activity. Int. J. Cardiol. 135, 257-259.
32. Sterin-Borda L., Gorelik G., Postan M., Gonzalez Cappa S., Borda E. (1999) Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association circulating beta-adrenoceptor-related autoantibodies. Cardiovasc. Res. 41, 116-125.
33. Talvani A., Rocha M.O.C., Ribeiro A.L., Borda E., Sterin-Borda L., Teixeira M.M. (2006) Levels of anti-M2 and anti-β1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. Microbes Infect. 8, 2459-2464.
34. Verani M.S., Hartung G.H., Hoepfel-Harris J., Welton D.E., Pratt C.M., Miller R.R. (1981) Effects of exercise training on left ventricular performance and myocardial perfusion in patients with coronary artery disease. Am. J. Cardiol. 47, 797-803.
35. WHO, World Health Organization (2005) Tropical Disease Research: Progress 2003-2004 seventeenth programme report of the UNICEF/UNDP/World Bank/WHO. Special Programme for Research & Training in Tropical Diseases (TRD). Programme report, n. 17. Geneva pp. 31-33.
36. 2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc. Res. 54, 162-174.